英検1級・薬剤耐性と抗菌薬【4技能横断】独自長文・要約・英作文・二次面接8問

結論：英検1級の薬剤耐性（AMR）を扱う場合、「薬を減らせば解決する」「新薬さえ開発すれば安心」といった単純化を避けることが大切です。必要な医療へのアクセス、薬の適正使用、感染予防、検査データの比較可能性を別の論点として説明する必要があります。慶英会ではWHOの公式資料を参考に、読解・リスニング・英文要約・意見論述・二次面接へ展開できる独自教材を制作しました。独自長文5問・聞き取り3問・追質問8問と全解答を掲載しています。

参考：WHOは2025年10月13日公開のGlobal antibiotic resistance surveillance report 2025で、薬剤耐性の監視と各国データの解釈に関する課題を整理しています。以下の地域医療ネットワークは慶英会が創作した架空事例です。実在の病院の統計や治療方針を示すものではありません。具体的な薬の使用・治療判断は医療者の指示に従ってください。

薬剤耐性を英検1級で説明する5つの視点

• ①治療：薬剤耐性は治療の有効性に関わるが、すべての感染症を同じように扱わない。
• ②適正使用：処方の総数と医学的な適切さを混同しない。
• ③予防：感染予防と新しい治療の開発を相互補完として考える。
• ④データ：検査を受けた患者群・方法・地域が異なると比較に注意が必要。
• ⑤公平性：不要な使用を減らしつつ必要な治療を受けられるようにする。

独自長文（378語）｜Antimicrobial Resistance and Public Responsibility

Paragraph 1. Antimicrobial resistance is often discussed as a problem that can be solved simply by developing stronger medicines. New treatments are important, but relying on future discoveries alone overlooks the many decisions that influence whether existing medicines remain effective. When microorganisms become resistant to a treatment, infections can be harder to manage. Inappropriate use of antimicrobial medicines can contribute to resistance, while weaknesses in infection prevention and the surveillance of resistant organisms make coordinated responses more difficult. Public policy must therefore connect the responsible use of medicines with access to appropriate care, prevention, and reliable evidence.

Paragraph 2. A fictional regional health network notices that its clinics report different patterns of antibiotic prescribing. Some administrators propose setting the same numerical target for every facility. Their intention is to reduce unnecessary treatment, but a single target could be misleading because clinics serve patients with different needs. A hospital treating complicated infections cannot necessarily be evaluated by the same crude measure as a clinic handling routine appointments. Equally, a decline in the number of prescriptions would not, by itself, prove that patients were receiving suitable treatment. The network therefore asks clinicians and researchers to review prescribing practices alongside the circumstances in which medicines are used.

Paragraph 3. Improved surveillance offers another opportunity. Laboratories can report resistance patterns, helping professionals identify where further attention is needed. However, data collected in one facility may not describe an entire population. Hospitals that test more severe cases might record different patterns from community clinics, and testing methods may vary. Decision-makers need to know who was tested, which organisms were identified, and whether the findings are comparable before drawing broad conclusions. Publishing large tables without such explanations could create an appearance of precision while encouraging inappropriate interpretations.

Paragraph 4. The fictional network develops a broader strategy. It supports professional training, clear public information, infection-prevention measures, and standardized reporting where practical. It also considers whether patients face barriers to timely diagnosis and appropriate treatment. Officials acknowledge that these activities require money and staff time, and that an improved reporting system cannot guarantee resistance will disappear. Their goal is to reduce avoidable misuse while protecting access for patients who genuinely need treatment. Success would be judged through several forms of evidence rather than a single prescription total or an impressive count of laboratory reports.

長文内容一致｜独自5問

Reading Q 1

What is the passage’s main argument?

• (A) Only new medicines can address antimicrobial resistance.
• (B) Antimicrobial resistance can be solved by reducing every prescription by the same percentage.
• (C) An effective response combines appropriate medicine use, prevention, surveillance, and access to care.
• (D) Every clinic should be judged by the total number of prescriptions it issues.

Reading Q 2

Why could the same prescribing target for every clinic be misleading?

• (A) Patient needs and clinical circumstances differ between facilities.
• (B) Every facility is required to prescribe exactly the same medicines.
• (C) There are no patients who require antimicrobial treatment.
• (D) Prescription numbers cannot be recorded.

Reading Q 3

What limitation of laboratory data does the author identify?

• (A) Laboratories can never observe resistant organisms.
• (B) Hospitals always use identical testing methods.
• (C) Resistance reports are irrelevant to public policy.
• (D) Different patient groups and methods can make direct comparisons unreliable.

Reading Q 4

Which statement best reflects the proposed network’s goals?

• (A) Prevent all patients from obtaining antibiotic treatment.
• (B) Reduce avoidable misuse without restricting appropriate access to needed care.
• (C) Focus only on the number of reports published.
• (D) Assume that professional training guarantees resistance will disappear.

Reading Q 5

What would be an appropriate way to evaluate the policy?

• (A) Declare success whenever the prescription total falls.
• (B) Ignore whether patients receive suitable treatment.
• (C) Examine several relevant outcomes and the context of prescribing decisions.
• (D) Count only how many laboratories join the network.

読解5問の全解答と本文根拠

Reading Q1 正解（C）An effective response combines appropriate medicine use, prevention, surveillance, and access to care.。第1段落と結論では、薬の適正使用・予防・監視・必要な医療へのアクセスを総合している。

Reading Q2 正解（A）Patient needs and clinical circumstances differ between facilities.。complicated infectionsの病院とroutine appointmentsの診療所では患者構成が異なる。

Reading Q3 正解（D）Different patient groups and methods can make direct comparisons unreliable.。検査対象・試験方法の違いが比較を難しくする。

Reading Q4 正解（B）Reduce avoidable misuse without restricting appropriate access to needed care.。avoid misuse while protect access for genuine needという二つの目的を保つ。

Reading Q5 正解（C）Examine several relevant outcomes and the context of prescribing decisions.。単一の処方数・報告件数だけでなく、複数の成果を検証すると結論。

独自リスニング台本（175語）｜Regional Clinic Meeting

この教材には音声ファイルは付属しません。台本を隠し、第三者や端末の読み上げで1回聞いた後に解答してください。合成音声は実際の英検録音の抑揚や速度を完全再現しません。英検1級の公式音源でも初見で練習しましょう。

At a fictional meeting of regional clinics, a health coordinator presents a plan to improve the use of antibiotics. One manager proposes rewarding facilities that issue the fewest prescriptions. A clinician replies that the number alone would be misleading. Clinics treat different patients, and some people genuinely require appropriate antibiotic treatment. The purpose should be to reduce unnecessary use without discouraging justified care. The coordinator then discusses laboratory data. Some facilities test mainly patients with complicated conditions, while others collect information from routine community visits. The reports can identify possible trends, but the figures should not be compared without checking which groups were tested and whether the methods were consistent. A representative asks whether the region should focus exclusively on developing new medicines. The coordinator explains that research remains valuable, but prevention, responsible prescribing, and surveillance are also important. The network therefore proposes training for staff, clearer public information, and improvements to reporting procedures. It will review both prescribing decisions and access to suitable treatment rather than treat lower prescription totals as proof of success.

リスニング独自3問

Listening Q 1

What concern does the clinician raise about rewarding the fewest prescriptions?

• (A) It could ignore differences in patient needs and discourage appropriate treatment.
• (B) It is impossible to count prescriptions.
• (C) It would require clinics to use more antibiotics in every case.
• (D) It would prevent laboratories from collecting information.

Listening Q 2

Why should the laboratory reports be compared carefully?

• (A) Only hospitals are allowed to test infections.
• (B) All clinics treat identical groups of patients.
• (C) The region has already stopped collecting data.
• (D) The patients selected for testing and the methods may differ.

Listening Q 3

What does the coordinator recommend?

• (A) Only investing in new medicines.
• (B) Combining training, prevention-related information, and better reporting with appropriate patient access.
• (C) Permanently prohibiting the prescription of antibiotics.
• (D) Using prescription counts as the only evidence of quality.

リスニングの全解答

Listening Q1 正解（A）It could ignore differences in patient needs and discourage appropriate treatment.。fewest number isn’t adequate; justified care remains necessary。

Listening Q2 正解（D）The patients selected for testing and the methods may differ.。which groups tested and methods consistent?

Listening Q3 正解（B）Combining training, prevention-related information, and better reporting with appropriate patient access.。research important but prevention/responsible prescribing/surveillance as well。

英文要約｜90〜110語でまとめる

上の読解英文について、対策の利点と制約・複数の評価方法を保持して英語で要約してください。

Antimicrobial resistance requires more than the development of new medicines. A fictional regional network considers reducing unnecessary antibiotic use, but uniform prescription targets could overlook differences in patient needs and discourage suitable treatment. Laboratory surveillance may identify resistance patterns, although results can be difficult to compare when patient groups and testing methods vary. The network therefore proposes professional training, infection prevention, clearer information, and standardized reporting where practical. These measures involve costs and cannot guarantee that resistance will disappear. Officials aim to reduce avoidable misuse while maintaining access to appropriate care and evaluating outcomes through several kinds of evidence.

99語。 架空の地域ネットワークを題材とし、実在統計を捏造していません。

意見論述｜政府は薬剤耐性対策を強化すべきか

Original TOPIC: Should governments invest more in programs to address antimicrobial resistance?

• 理由1：適正な使用を支える教育。
• 理由2：比較可能な検査・監視データ。
• 理由3：感染予防と必要な医療へのアクセス。
• 反論：費用・事務負担と政策評価。

Governments should invest more in programs that address antimicrobial resistance, but their strategies should not focus exclusively on restricting the use of medicines. Responsible policy must protect the effectiveness of treatment while ensuring that patients can still receive appropriate care. First, better information and professional training can reduce avoidable misuse. Decisions about treatment should reflect clinical circumstances rather than a crude target for the number of prescriptions. Clinics serve different groups of patients, so identical numerical goals may produce misleading comparisons. Second, improved surveillance can help institutions recognize problems and evaluate responses. Reliable reporting requires clear information about who was tested and how results were collected. Without that context, a large database may create unjustified confidence in a conclusion that does not apply to every population. Third, infection prevention and timely access to diagnosis can support the responsible use of resources. Preventing avoidable infections is important alongside developing new treatments. Public funding can help organizations coordinate procedures that would be difficult to maintain independently. Critics may worry about expense and additional administrative work. That concern is reasonable, which is why programs should be proportionate and reviewed using several meaningful outcomes rather than a single headline figure. Overall, I support coordinated investment in training, prevention, surveillance, and suitable care. The objective should be to reduce avoidable resistance-related risks without making necessary treatment inaccessible.

222語。 主張と独立した3理由、現実的な留保を配置した慶英会の独自答案です。

二次面接｜独自スピーチと追質問8問

Original TOPIC: Should governments strengthen efforts to address antimicrobial resistance?

I believe governments should strengthen efforts to address antimicrobial resistance, but simply reducing the number of antibiotic prescriptions is not enough. An effective approach must consider both the responsible use of medicines and access to appropriate treatment. My first reason is education. Health professionals and the public need reliable information about when treatments are appropriate. A simple numerical target may be misleading because clinics serve patients with different medical needs. Second, good surveillance can improve decisions. Laboratories may identify changes in resistance patterns, but officials should examine who was tested and how the information was collected before making broad claims. Third, prevention matters. Better infection-prevention procedures and access to timely diagnosis can complement the development of new medicines. The goal should be to reduce avoidable problems rather than expect a single technological solution. Of course, these measures cost money and require coordination. Governments should therefore assess which activities produce useful outcomes, while maintaining appropriate care for patients who need it. In conclusion, I support a balanced strategy combining professional training, reliable evidence, prevention, and access to treatment. Public health measures should be evaluated carefully rather than judged by the number of prescriptions alone.

モデルスピーチ193語。 本番の一律語数指定ではありません。ご自身の話速で2分間の練習を行ってください。

Interview Q1

Question: Should doctors simply prescribe fewer antibiotics?

Model answer: Prescribing should be appropriate to the individual case. A lower overall number is not enough to establish that patients received suitable care.

Interview Q2

Question: Why is antimicrobial resistance a public issue?

Model answer: Resistant infections can affect communities, and prevention, surveillance, and access to care often require coordination across institutions.

Interview Q3

Question: Can new drugs solve the problem by themselves?

Model answer: New treatments may help, but prevention and responsible use remain important. No single approach should be assumed sufficient.

Interview Q4

Question: Why might hospital data be misleading?

Model answer: Hospitals and clinics may test different groups of patients, so their results cannot automatically represent the whole population.

Interview Q5

Question: Should governments finance surveillance?

Model answer: Targeted funding can improve comparable reporting, provided data quality, privacy, and practical public-health uses are considered.

Interview Q6

Question: Could restrictions harm patients?

Model answer: Poorly designed restrictions could discourage appropriate treatment. Decisions should reflect clinical needs rather than arbitrary numerical limits.

Interview Q7

Question: How would you judge whether a program works?

Model answer: I would examine prescribing decisions, access to suitable treatment, prevention efforts, and the reliability of surveillance evidence.

Interview Q8

Question: What would justify changing a policy?

Model answer: If evidence showed that it delayed necessary care or failed to reduce avoidable misuse, officials should revise its design.

薬剤耐性の社会問題語彙20表現

英語	意味
antimicrobial resistance	薬剤耐性
antibiotic	抗菌薬・抗生物質
antimicrobial medicine	抗微生物薬
resistant organism	耐性をもつ微生物
appropriate treatment	適切な治療
prescribing practice	処方慣行
surveillance	継続的監視
infection prevention	感染予防
laboratory testing	検査室での検査
clinical circumstances	臨床上の事情
data comparability	データの比較可能性
patient population	患者集団
public health	公衆衛生
diagnosis	診断
misuse	不適切な使用
standardized reporting	標準化された報告
access to care	医療へのアクセス
health-care facility	医療機関
treatment effectiveness	治療の有効性
evidence-based policy	根拠に基づく政策

4技能へ転用する独自6例

転用1｜数値と適切性

英語：Fewer prescriptions do not necessarily mean that treatment has become more appropriate.

解説：処方数だけで質を断定しない。

転用2｜監視と一般化

英語：Data from one clinic may not represent a whole population.

解説：施設ごとの患者の違い。

転用3｜新薬と予防

英語：Developing medicines should complement rather than replace prevention.

解説：薬の開発だけに依存しない。

転用4｜アクセスと規制

英語：Measures to reduce misuse must preserve access to needed treatment.

解説：適切な治療を妨げない。

転用5｜原因と条件

英語：Comparisons require information about who was tested and how.

解説：比較する条件を確認する。

転用6｜成果の評価

英語：Successful programs need several indicators rather than a single target.

解説：複数の評価指標が必要。

7日間の横断型学習

• 1日目：独自長文を読み5問の根拠を確認。
• 2日目：重要語彙20表現と6つの言い換えを復習。
• 3日目：リスニング台本を隠して独自3問を1回聞きで解答。
• 4日目：本文を90〜110語に要約。
• 5日目：独自TOPICで理由3つの意見論述を書く。
• 6日目：1分準備→2分スピーチ→追質問8問。
• 7日目：英検協会の未使用問題で初見の論理を確認。

FAQ

薬剤耐性は英検1級に必ず出題されますか？

特定テーマの出題は保証できません。本記事はWHOの公衆衛生分野を参考にした慶英会の独自演習です。

抗菌薬の処方数が減れば薬剤耐性は解決しますか？

処方数だけでは適切さを測れません。患者群や診断などの条件が異なるため、必要な治療へのアクセスと適正使用を分けて考えます。

薬剤耐性と英作文の医療知識はどこまで必要ですか？

専門的な診療判断を覚えるのではなく、本文の情報を正確に理解し、予防・監視・費用・公平性の関係を説明する学習です。

参考にした主な公式情報

• WHO｜Global antibiotic resistance surveillance report 2025
• WHO｜Antimicrobial resistance fact sheet
• 日本英語検定協会｜英検1級の形式
• 高齢化社会・介護人材の4技能教材
• 英検1級の無料教材総合ガイド

慶英会の英検1級無料体験・学習相談

社会問題の長文は読めても、意見論述と面接へ応用できない場合は論点を整理して同じテーマを4技能で反復します。最大1か月無料体験・学習相談はこちら。独自教材は無料・登録不要です。

慶英会・英検1級の関連する社会問題無料教材：公共交通のアクセシビリティの4技能教材 ／ 高齢化社会・介護人材の4技能教材 ／ 移住労働者・言語支援の4技能教材。英検1級の総合教材ガイドにも独自問題・全解答をまとめています。

慶英会の英検1級関連無料教材：PM2.5・NO₂と都市の大気汚染を読む独自教材｜長文・聴解・要約・意見論述・面接と全解答。独自の架空事例と公式一次情報を区別して学べます。

慶英会の関連する英検1級無料教材：WHO結核報告2025｜推計・診断・報告の独自24修正例と4択12問。公式情報を参照した独自の問題・全解答を公開しています。英検1級総合ガイド／無料体験・学習相談。

最大1ヶ月無料体験授業受付中！（残り枠わずかです！）

最大1ヶ月の「完全無料」指導体験
平均2~3時間のレッスン ＋ 毎日LINEサポート付き

ご入塾前に、慶英会の圧倒的な指導品質をじっくりご体感ください。

無料体験だけで成績が上がる方も続出!!
保護者様の教育相談も無料で承ります。

1.学年 2. 学習目標　3.体験ご希望をお送りください。

⚠️【塾長直接指導の残り枠わずか】
枠が埋まり次第終了となります。お早めにお申し込みください。

最大1ヶ月無料体験（残り枠わずか）Eメールでのお申し込み